The Use-Case: Life AI - Tuan Cao (Episode #54

The Use-Case: Life AI - Tuan Cao (Episode #54

From Scenius Studio by Scenius Capital

May 7, 2025 · 54 min

About this episode

Tuan Cao discusses the innovative approach of Life AI in decentralized genetics and personalized medicine.

In this episode, I sit down with Tuan Cao, co-founder of Life AI. Tuan and his team started by building a web 2 alternative to 23 and Me, focused on the Asian genome. But with the key difference, they gave users full control over their data. That was just the beginning of a long road to build one of the industry's leading decentralized science projects. Long before decI was even a term, Life AI has been building a decentralized foundation for genetics-based medicine and research. Today, Life AI has established itself as a baseler protocol that traditional healthcare players are building on top of cheaply and quickly. The future of genetic-based personalized treatments might have crypto underneath the hood. Let's get into it. Connect with the guest Life AI ⁠https://www.lifenetwork.ai/en Follow Life AI on Twitter/X ⁠https://x.com/lifenetwork_ai Disclaimer Ben Jacobs is a partner at Scenius Capital Management. All views expressed by Ben and the guests of this podcast are solely their opinions and do not reflect the opinions of Scenius Capital Management. Guests and the host may maintain positions in the assets or funds discussed in this podcast. You should not treat any opinion…

People in this episode

Host: Ben Jacobs

Guest: Tuan Cao

Topics covered

  • genetics
  • decentralized science
  • healthcare
  • personalized medicine
  • data control

Keywords

  • Life AI
  • genome
  • decentralized science
  • genetics-based medicine
  • crypto

Mentioned in this episode

Organizations: Life AI, Scenius Capital Management

Products: 23 and Me

More episodes of Scenius Studio

Explore listener stats, chart rankings, contacts and more on the Scenius Studio podcast page.